Interleukin & HIV/AIDS: Research
The Basics
- Research Shows Treating HIV/AIDS With Interleukin-2 Is Ineffective (October 23, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Interleukin-2 (May 30, 2009)
To read PDF, click here
From AIDS InfoNet
- Interleukin-2 (IL-2, Proleukin) (March 2007)
To read PDF, click here
From Project Inform
- IL-2 (August 15, 2006)
From AIDS Treatment Data Network
- The Development Pipeline for Cytokines, Immunomodulators and Gene Therapy (September 29, 2005)
In TAGline, from Treatment Action Group
- An Overview of Aldesleukin (IL-2, Proleukin) (March 10, 2004)
To read PDF, click here
From U.S. National Institutes of Health
Open Trials
Trial Results
- IL-2 Confers No Long-Term Benefits (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Intriguing IL2 Study Results May Offer Unique Solution (August 6, 2008)
From Project Inform
- Interleukin-2 Ineffective in Maintaining Baseline CD4+ Cell Count During Treatment Interruption (February 6, 2008)
From The Body PRO
- TILT: A Look at the Role of Interleukin-2 in Treatment Interruption Leans Toward the Negative (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Interleukin-2 Expands Select CD4+ T-Cell Populations, but Has No Effect on HIV-Specific Immune Responses (February 26, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Scientists Explore Possible New Way to Fight AIDS (February 8, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Patients Get Long-Term Boost With Short, Intermittent Drug Regimen (April 26, 2004)
From U.S. National Institute of Allergy and Infectious Diseases
Interviews with Doctors
|
|
Advertisement
|
E-Mail
Glossary
Share
